Unexpected diversity of cellular immune responses against Nef and Vif in HIV-1-infected patients who spontaneously control viral replication.

HIV-1-infected individuals who spontaneously control viral replication represent an example of successful containment of the AIDS virus. Understanding the anti-viral immune responses in these individuals may help in vaccine design. However, immune responses against HIV-1 are normally analyzed using...

Full description

Bibliographic Details
Main Authors: Leandro F Tarosso, Mariana M Sauer, Sabri Sanabani, Maria Teresa Giret, Helena I Tomiyama, John Sidney, Shari M Piaskowski, Ricardo S Diaz, Ester C Sabino, Alessandro Sette, Jorge Kalil-Filho, David I Watkins, Esper G Kallas
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2010-07-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC2896403?pdf=render
_version_ 1818194818001534976
author Leandro F Tarosso
Mariana M Sauer
Sabri Sanabani
Maria Teresa Giret
Helena I Tomiyama
John Sidney
Shari M Piaskowski
Ricardo S Diaz
Ester C Sabino
Alessandro Sette
Jorge Kalil-Filho
David I Watkins
Esper G Kallas
author_facet Leandro F Tarosso
Mariana M Sauer
Sabri Sanabani
Maria Teresa Giret
Helena I Tomiyama
John Sidney
Shari M Piaskowski
Ricardo S Diaz
Ester C Sabino
Alessandro Sette
Jorge Kalil-Filho
David I Watkins
Esper G Kallas
author_sort Leandro F Tarosso
collection DOAJ
description HIV-1-infected individuals who spontaneously control viral replication represent an example of successful containment of the AIDS virus. Understanding the anti-viral immune responses in these individuals may help in vaccine design. However, immune responses against HIV-1 are normally analyzed using HIV-1 consensus B 15-mers that overlap by 11 amino acids. Unfortunately, this method may underestimate the real breadth of the cellular immune responses against the autologous sequence of the infecting virus.Here we compared cellular immune responses against nef and vif-encoded consensus B 15-mer peptides to responses against HLA class I-predicted minimal optimal epitopes from consensus B and autologous sequences in six patients who have controlled HIV-1 replication. Interestingly, our analysis revealed that three of our patients had broader cellular immune responses against HLA class I-predicted minimal optimal epitopes from either autologous viruses or from the HIV-1 consensus B sequence, when compared to responses against the 15-mer HIV-1 type B consensus peptides.This suggests that the cellular immune responses against HIV-1 in controller patients may be broader than we had previously anticipated.
first_indexed 2024-12-12T01:08:20Z
format Article
id doaj.art-d3df9a7463ff4bb6b28e4c0f8579e159
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-12T01:08:20Z
publishDate 2010-07-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-d3df9a7463ff4bb6b28e4c0f8579e1592022-12-22T00:43:32ZengPublic Library of Science (PLoS)PLoS ONE1932-62032010-07-0157e1143610.1371/journal.pone.0011436Unexpected diversity of cellular immune responses against Nef and Vif in HIV-1-infected patients who spontaneously control viral replication.Leandro F TarossoMariana M SauerSabri SanabaniMaria Teresa GiretHelena I TomiyamaJohn SidneyShari M PiaskowskiRicardo S DiazEster C SabinoAlessandro SetteJorge Kalil-FilhoDavid I WatkinsEsper G KallasHIV-1-infected individuals who spontaneously control viral replication represent an example of successful containment of the AIDS virus. Understanding the anti-viral immune responses in these individuals may help in vaccine design. However, immune responses against HIV-1 are normally analyzed using HIV-1 consensus B 15-mers that overlap by 11 amino acids. Unfortunately, this method may underestimate the real breadth of the cellular immune responses against the autologous sequence of the infecting virus.Here we compared cellular immune responses against nef and vif-encoded consensus B 15-mer peptides to responses against HLA class I-predicted minimal optimal epitopes from consensus B and autologous sequences in six patients who have controlled HIV-1 replication. Interestingly, our analysis revealed that three of our patients had broader cellular immune responses against HLA class I-predicted minimal optimal epitopes from either autologous viruses or from the HIV-1 consensus B sequence, when compared to responses against the 15-mer HIV-1 type B consensus peptides.This suggests that the cellular immune responses against HIV-1 in controller patients may be broader than we had previously anticipated.http://europepmc.org/articles/PMC2896403?pdf=render
spellingShingle Leandro F Tarosso
Mariana M Sauer
Sabri Sanabani
Maria Teresa Giret
Helena I Tomiyama
John Sidney
Shari M Piaskowski
Ricardo S Diaz
Ester C Sabino
Alessandro Sette
Jorge Kalil-Filho
David I Watkins
Esper G Kallas
Unexpected diversity of cellular immune responses against Nef and Vif in HIV-1-infected patients who spontaneously control viral replication.
PLoS ONE
title Unexpected diversity of cellular immune responses against Nef and Vif in HIV-1-infected patients who spontaneously control viral replication.
title_full Unexpected diversity of cellular immune responses against Nef and Vif in HIV-1-infected patients who spontaneously control viral replication.
title_fullStr Unexpected diversity of cellular immune responses against Nef and Vif in HIV-1-infected patients who spontaneously control viral replication.
title_full_unstemmed Unexpected diversity of cellular immune responses against Nef and Vif in HIV-1-infected patients who spontaneously control viral replication.
title_short Unexpected diversity of cellular immune responses against Nef and Vif in HIV-1-infected patients who spontaneously control viral replication.
title_sort unexpected diversity of cellular immune responses against nef and vif in hiv 1 infected patients who spontaneously control viral replication
url http://europepmc.org/articles/PMC2896403?pdf=render
work_keys_str_mv AT leandroftarosso unexpecteddiversityofcellularimmuneresponsesagainstnefandvifinhiv1infectedpatientswhospontaneouslycontrolviralreplication
AT marianamsauer unexpecteddiversityofcellularimmuneresponsesagainstnefandvifinhiv1infectedpatientswhospontaneouslycontrolviralreplication
AT sabrisanabani unexpecteddiversityofcellularimmuneresponsesagainstnefandvifinhiv1infectedpatientswhospontaneouslycontrolviralreplication
AT mariateresagiret unexpecteddiversityofcellularimmuneresponsesagainstnefandvifinhiv1infectedpatientswhospontaneouslycontrolviralreplication
AT helenaitomiyama unexpecteddiversityofcellularimmuneresponsesagainstnefandvifinhiv1infectedpatientswhospontaneouslycontrolviralreplication
AT johnsidney unexpecteddiversityofcellularimmuneresponsesagainstnefandvifinhiv1infectedpatientswhospontaneouslycontrolviralreplication
AT sharimpiaskowski unexpecteddiversityofcellularimmuneresponsesagainstnefandvifinhiv1infectedpatientswhospontaneouslycontrolviralreplication
AT ricardosdiaz unexpecteddiversityofcellularimmuneresponsesagainstnefandvifinhiv1infectedpatientswhospontaneouslycontrolviralreplication
AT estercsabino unexpecteddiversityofcellularimmuneresponsesagainstnefandvifinhiv1infectedpatientswhospontaneouslycontrolviralreplication
AT alessandrosette unexpecteddiversityofcellularimmuneresponsesagainstnefandvifinhiv1infectedpatientswhospontaneouslycontrolviralreplication
AT jorgekalilfilho unexpecteddiversityofcellularimmuneresponsesagainstnefandvifinhiv1infectedpatientswhospontaneouslycontrolviralreplication
AT davidiwatkins unexpecteddiversityofcellularimmuneresponsesagainstnefandvifinhiv1infectedpatientswhospontaneouslycontrolviralreplication
AT espergkallas unexpecteddiversityofcellularimmuneresponsesagainstnefandvifinhiv1infectedpatientswhospontaneouslycontrolviralreplication